When less is more: Novel mechanisms of iron conservation

Trends in Endocrinology and Metabolism

Volumn 24, Issue 11, 2013, Pages 569-577

  Bayeva, Marina ^a   Chang, Hsiang Chun ^a   Wu, Rongxue ^a   Ardehali, Hossein ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cth1 2; Diabetes; Iron deficiency; Metabolism; Tristetraprolin

Indexed keywords

GLUCOSE; HEME; HEME OXYGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INSULIN; INSULIN RECEPTOR; IRON; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MESSENGER RNA; MITOCHONDRIAL PROTEIN; TRISTETRAPROLIN;

CELL METABOLISM; ENERGY METABOLISM; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON DEPLETION; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; LIPID METABOLISM; MAMMAL CELL; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION; YEAST;

CTH1/2; DIABETES; IRON DEFICIENCY; METABOLISM; TRISTETRAPROLIN;

ANIMALS; DIABETES MELLITUS; HUMANS; IRON; IRON-REGULATORY PROTEINS; TRISTETRAPROLIN;

EID: 84886305458     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.07.003     Document Type: Review

References (51)

1. McLean E., et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009, 12:444-454.
2. Center for Disease Control, USA (2002) Iron deficiency-United States, 1999-2000. MMWR Morb. Mortal. Wkly. Rep. 51, 897-899.
3. Milman N. Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int. J. Hematol. 1996, 63:103-135.
4. Sinclair L.M., Hinton P.S. Prevalence of iron deficiency with and without anemia in recreationally active men and women. J. Am. Diet. Assoc. 2005, 105:975-978.
5. Agarwal R. Nonhematological benefits of iron. Am. J. Nephrol. 2007, 27:565-571.
6. Patterson A.J., et al. Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual. Life Res. 2000, 9:491-497.
7. Brownlie T., et al. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am. J. Clin. Nutr. 2004, 79:437-443.
8. Wilson M.T., Reeder B.J. Oxygen-binding haem proteins. Exp. Physiol. 2008, 93:128-132.
9. Furukawa T., et al. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis. Life Sci. 1992, 50:2059-2065.
10. Gari K., et al. MMS19 links cytoplasmic iron-sulfur cluster assembly to DNA metabolism. Science 2012, 337:243-245.
11. Kispal G., et al. Biogenesis of cytosolic ribosomes requires the essential iron-sulphur protein Rli1p and mitochondria. EMBO J. 2005, 24:589-598.
12. Shakoury-Elizeh M., et al. Metabolic response to iron deficiency in Saccharomyces cerevisiae. J. Biol. Chem. 2010, 285:14823-14833.
13. Bhaskar B., et al. Iron: heme proteins, peroxidases, catalases & catalase-peroxidases. Encyclopedia of Inorganic Chemistry 2006, John Wiley and Sons. R.B. King (Ed.).
14. De Matteis F., Marks G.S. Cytochrome P450 and its interactions with the heme biosynthetic pathway. Can. J. Physiol. Pharmacol. 1996, 74:1-8.
15. Nemeth E., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
16. Mastrogiannaki M., et al. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J. Clin. Invest. 2009, 119:1159-1166.
17. Shah Y.M., et al. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 2009, 9:152-164.
18. Lok C.N., Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 1999, 274:24147-24152.
19. Liu Y.L., et al. Regulation of ferrochelatase gene expression by hypoxia. Life Sci. 2004, 75:2035-2043.
20. Peyssonnaux C., et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 2007, 117:1926-1932.
21. Mole D.R. Iron homeostasis and its interaction with prolyl hydroxylases. Antioxid. Redox. Signal. 2010, 12:445-458.
22. Evstatiev R., Gasche C. Iron sensing and signalling. Gut 2012, 61:933-952.
23. Anderson G.J., Vulpe C.D. Mammalian iron transport. Cell. Mol. Life Sci. 2009, 66:3241-3261.
24. Anderson C.P., et al. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim. Biophys. Acta 2012, 1823:1468-1483.
25. Thompson J.W., et al. Structural and molecular characterization of iron-sensing hemerythrin-like domain within F-box and leucine-rich repeat protein 5 (FBXL5). J. Biol. Chem. 2012, 287:7357-7365.
26. Philpott C.C., Protchenko O. Response to iron deprivation in Saccharomyces cerevisiae. Eukaryot. Cell 2008, 7:20-27.
27. Shakoury-Elizeh M., et al. Transcriptional remodeling in response to iron deprivation in Saccharomyces cerevisiae. Mol. Biol. Cell 2004, 15:1233-1243.
28. Puig S., et al. Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell 2005, 120:99-110.
29. Philpott C.C., et al. Metabolic remodeling in iron-deficient fungi. Biochim. Biophys. Acta 2012, 1823:1509-1520.
30. Phalip V., et al. Characterization of the biotin biosynthesis pathway in Saccharomyces cerevisiae and evidence for a cluster containing BIO5, a novel gene involved in vitamer uptake. Gene 1999, 232:43-51.
31. Stolz J. Isolation and characterization of the plasma membrane biotin transporter from Schizosaccharomyces pombe. Yeast 2003, 20:221-231.
32. Protchenko O., Philpott C.C. Regulation of intracellular heme levels by HMX1, a homologue of heme oxygenase, in Saccharomyces cerevisiae. J. Biol. Chem. 2003, 278:36582-36587.
33. Bayeva M., et al. mTOR regulates cellular iron homeostasis through tristetraprolin. Cell Metab. 2012, 16:645-657.
34. Pedro-Segura E., et al. The Cth2 ARE-binding protein recruits the Dhh1 helicase to promote the decay of succinate dehydrogenase SDH4 mRNA in response to iron deficiency. J. Biol. Chem. 2008, 283:28527-28535.
35. Puig S., et al. Cooperation of two mRNA-binding proteins drives metabolic adaptation to iron deficiency. Cell Metab. 2008, 7:555-564.
36. Afonso S., et al. Protoporphyrin IX and oxidative stress. Free Radic. Res. 1999, 31:161-170.
37. Rao R., et al. Metabolomic analysis of cerebrospinal fluid indicates iron deficiency compromises cerebral energy metabolism in the infant monkey. Neurochem. Res. 2013, 38:573-580.
38. Algarin C., et al. Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr. Res. 2003, 53:217-223.
39. Yu G.S., et al. Effect of prenatal iron deficiency on myelination in rat pups. Am. J. Pathol. 1986, 125:620-624.
40. Lisi L., et al. The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. J. Neuroinflammation 2011, 8:1.
41. Marderosian M., et al. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene 2006, 25:6277-6290.
42. Cao H., et al. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes. Obesity (Silver Spring) 2008, 16:1208-1218.
43. Lin N.Y., et al. Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes. FEBS J. 2007, 274:867-878.
44. Lai W.S., et al. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J. Biol. Chem. 1990, 265:16556-16563.
45. Bouchard L., et al. ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes. Surg. 2007, 17:372-382.
46. Bouchard L., et al. Visceral adipose tissue zinc finger protein 36 mRNA levels are correlated with insulin, insulin resistance index, and adiponectinemia in women. Eur. J. Endocrinol. 2007, 157:451-457.
47. Jiang R., et al. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004, 291:711-717.
48. Tuomainen T.P., et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997, 20:426-428.
49. Zhao Z., et al. Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis. PLoS ONE 2012, 7:e41641.
50. Cooksey R.C., et al. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E1236-E1243.
51. Liu Q., et al. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr. Med. Chem. 2009, 16:113-129.